# Digiasia Bios

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/digiasia-bios

- Industry: Software
- Headquarters: Jakarta, Indonesia
- Website: www.digiasia.asia
- Total disclosed funding: $39M
- Latest round: Series A (Mar 2, 2020)
- Investors on record: 6

## About

Based in Indonesia, Digiasia Bios is a financial technology company specializing in innovative fintech solutions that facilitate seamless financial transactions for enterprises across diverse sectors.Digiasia Bios, founded in 2017 and headquartered in Jakarta, Indonesia, focuses on providing fintech solutions tailored for B2B and B2C transactions. The company has secured a total of USD 18.005 mn in funding across three deals, with the latest being a Series B round led by Mastercard Incorporated on April 14, 2021. Alexander Rusli and Prashant Gokarn are the founders of the company, bringing expertise from their previous entrepreneurial endeavors to further drive Digiasia's mission. The current valuation of Digiasia Bios stands at USD 225.002 mn.Digiasia Bios offers a comprehensive suite of fintech solutions designed to facilitate seamless financial transactions for enterprises across various sectors. Its core product offerings include B2B and B2C payments, remittance services, point-of-sale (POS) lending, and embedded finance solutions such as Buy Now Pay Later and trade financing. These services are primarily delivered through their Embedded Finance as a Service (EFaaS) APIs, which allow enterprise partners to integrate financial functionalities directly into their applications and transaction workflows. The company services a diverse client base that includes micro, small, and medium enterprises, tech platform providers, and retail entities, enabling them to enhance their customer engagement and transaction efficiency. Digiasia Bios operates in various geographical markets, focusing on regions that demand innovative fintech solutions, including Southeast Asia and broader Asian markets.Digiasia Bios generates revenue through various transaction-based models, leveraging its fintech products to serve both businesses and end consumers. The company’s diverse offerings create multiple revenue streams, particularly from partnerships with enterprises that utilize its APIs for financial services. For instance, a retail partner may incorporate the digital wallet solution into their native application, facilitating transactions that involve payment processing fees for each transaction executed through the wallet. Additionally, enterprises can subscribe to specific services such as the cash management system or remittance product, reinforcing a steady revenue model based on usage and transactional volume. The financial technology lending solutions also contribute to revenue by offering installment plans without the need for credit cards, allowing enterprises to monetize their customer financing options effectively.Digiasia Bios plans to utilize the USD 18 mn raised in the Series B funding round to scale its B2B fintech product suite and enhance its talent pool. The company is also looking to expand into new markets in Southeast Asia, with specific plans to enter additional Asian markets by 2023. Furthermore, Digiasia is focused on developing new products that will enhance its service offerings, leveraging the latest technologies to meet market demands.

## Funding rounds

- Series A, Mar 2, 2020, $39M — Mastercard Incorporated, Archimedes New Ventures, Blowfish Ventures Limited, GREAT MERITUS HOLDINGS LTD, PT. Artha Sekuritas Indonesia, Interchange Payments Group Holdings

## Investors

- Mastercard Incorporated — Series A
- Archimedes New Ventures (https://capitalatlas.ai/funds/archimedes-new-ventures) — Series A
- Blowfish Ventures Limited — Series A
- GREAT MERITUS HOLDINGS LTD — Series A
- PT. Artha Sekuritas Indonesia — Series A
- Interchange Payments Group Holdings — Series A